This site is intended for health professionals only

Editor’s pick

Dupixent hits endpoints in Phase III paediatric trial
Which patients benefit best from using pill organisers?
Dupilumab approved by EC for adolescents with moderate-to-severe atopic dermatitis
NICE recommends additional treatment option for people with early breast cancer
UK charity announces research investment to find Parkinson’s drug
Shrinking brain tumours and opening the door for targeted cancer therapies
Immunotherapy success for treatment-resistant lymphoma
AI reveals new breast cancer types that respond differently to treatment
Scottish capital is global hotspot for inflammatory bowel disease rates


Most read

1
User-friendly osteoporosis therapy launched
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Issues affecting access to orphan drugs in Europe
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe